ZAROXOLYN
What it isNCC-inhibiting thiazide-like diuretic; refractory edema in heart failure and kidney disease.
Why this oneIts pronounced synergy with loop diuretics makes it a rescue for diuretic-resistant edema even at low GFR.
What limits itThe combined diuresis can be profound — check electrolytes and volume within days. It is not interchangeable with other thiazides.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Edema of cardiac failure | Adult | 5–20 mg QD | ||
| Edema of renal disease | Adult | 5–20 mg QD | ||
| Mild–moderate essential hypertension | Adult | 2.5–5 mg QD |
Renal Undefined (contraindicated in anuria)
Hepatic Undefined (contraindicated in hepatic coma/precoma)
Pregnancy Use only if clearly needed; crosses placenta; risk of fetal/neonatal jaundice and thrombocytopenia
Lactation Undefined
⚠ BOXED WARNING
Principal riskProfound diuresis and electrolyte loss when added to a loop diuretic
Cost, est. cash$5–$150/month
Generic entry2003
Legacy pregnancy categoryC
Defining liabilityVolume depletion and electrolyte disturbances; kidney function and interacting medications modify risk.

Open Metolazone in the interactive console ↗

